BIOMERICA INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
BIOMERICA INC (BMRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 48.91 thousand shares for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-31
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-05-31 was 67.75K shares, a 90.85% increase year-over-year.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-02-28 was 25.25K shares.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2022-05-31 was 35.50K shares.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2019-02-28 was 20.75K shares, a 245.83% increase year-over-year.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2026 was 48.91K shares, a 32.40% decline from fiscal 2025.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 72.34K shares, a 190.46% increase from fiscal 2024.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 24.91K shares, a 85.81% decline from fiscal 2023.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 175.50K shares, a 173.15% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | 48.91K shares 10-K · filed 2026-08-31 | ||||
| 2025-05-31 | 72.34K shares 10-K · filed 2026-08-31 | ||||
| 2024-05-31 | 24.91K shares 10-K · filed 2025-08-29 | 201.50K shares 10-K · filed 2024-08-28 | |||
| 2023-05-31 | 67.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | 93.00K shares derived: sum of 2 quarters · filed 2024-08-28 | 175.50K shares 10-K · filed 2024-08-28 | ||
| 2023-02-28 | 25.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-14 | 107.75K shares 10-Q · filed 2023-04-14 | |||
| 2022-11-30 | 82.50K shares 10-Q · filed 2023-01-13 | ||||
| 2022-05-31 | 35.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-25 | 64.25K shares 10-K · filed 2023-08-25 | |||
| 2022-02-28 | 28.75K shares 10-Q · filed 2022-04-14 | ||||
| 2019-02-28 | 20.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-15 | 44.25K shares 10-Q · filed 2019-04-15 | |||
| 2018-11-30 | 23.50K shares 10-Q · filed 2019-01-14 | ||||
| 2018-02-28 | 6.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-16 | 10.63K shares 10-Q · filed 2018-04-16 | |||
| 2017-11-30 | 4.63K shares 10-Q · filed 2018-01-17 | ||||
| 2017-02-28 | 6.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-14 | 11.50K shares 10-Q · filed 2017-04-14 | |||
| 2016-11-30 | 5.00K shares 10-Q · filed 2017-01-17 | ||||
| 2016-02-29 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-04-14 | 21.38K shares 10-Q · filed 2016-04-14 | |||
| 2015-11-30 | 21.38K shares 10-Q · filed 2016-01-14 | ||||
| 2015-02-28 | 1.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-14 | 35.50K shares 10-Q · filed 2015-04-14 | |||
| 2014-11-30 | 34.50K shares 10-Q · filed 2015-01-14 | ||||
| 2014-02-27 | -10.00K shares 10-Q · filed 2014-04-14 | ||||
| 2013-11-30 | 10.00K shares 10-Q · filed 2014-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |